OPKO Health (NYSE: OPK) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $276.2 million versus the consensus estimate of $286.52 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.